Table 3.

Clinical and biologic characteristics of patients with HCV cirrhosis and varices (OV) according to the propranolol treatment or not

VariablesPatients treated by propranolol (N = 50)Patients not treated by propranolol (N = 43)P
Age, y (±SD)61.1 ± 1257.7 ± 120.18
BMI, kg/m224.8 ± 426.7 ± 50.06
Male23 (46%)27 (62%)0.07
Mixed etiology15 (30%)18 (42%)0.23
Diabetes (yes)17 (35%)15 (38%)0.84
Serum AFP, ng/mL32 ± 1489.6 ± 90.61
Prothrombin activity (%)76 ± 1672 ± 190.35
Serum albumin, g/L40.5 ± 5.138.8 ± 5.80.14
Serum bilirubin, μ/mL19.7 ±1621.5 ± 170.70
Platelet count, ×109/L107 ± 57117 ± 480.19
Alkaline phosphatase (ULN)1.11.10.9
Varices grade ≥2 (%)30 (60%)28 (65%)0.82
Child–Pugh B5 (10%)5 (11.6%)1.00
Band ligation (%)38 (76%)34 (79%)0.70

NOTE: Data are expressed as mean ± SD, median (IQR), or number (percentage). Mixed etiology for past or ongoing daily alcohol intake >30 g/d.

Abbreviations: ALT, ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, γ-glutamyltransferase; ULN, upper normal limit range.